Beta Drugs Ltd
The live share price of Beta Drugs Ltd (BETA) as on 18 Apr 9:55am is ₹1,379.95 from NSE/BSE.
BETA NSE
₹1,379.95 ▲1.85% (25.1)
As on Apr 18, 2024 03:25 PM IST
Key Metrics
PE Ratio
0
PB Ratio
10.6
Dividend Yield
-
Sector PB
5.9
Sector PE
51.76
Sector Div Yld
0.56%
Dividend Yield
Dividend per share for the most recent financial year divided by the close price
About
Beta Drugs Limited is a pharmaceutical formulation manufacturing company. It is engaged in developing, manufacturing and marketing of drug products for domestic and international customers. The Company also engaged manufacturing oncology products
The following charts display the financial performance of the Beta Drugs Ltd (BETA) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.
Furthermore, under the Peers section, you can find stocks that are similar to Beta Drugs Ltd (BETA), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.
✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.
A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.
All smallcases are created and managed by SEBI-registered investment experts.
To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.
Financials
Income Statement
(INR) | Y/Y Change | |
Revenue | 227 Cr | +23.43% |
Operating Expense | 16 Cr | +24.12% |
Net Income | 30 Cr | +23.68% |
Net Profit Margin | 13.48% | +0.22% |
Earning Per Share | 31 | +23.67% |
EBITDA | 53 Cr | +23.95% |
Balance sheet
(INR) | Y/Y Change | |
Cash & short-term Inv | 19 Cr | +10.62% |
Total Assets | 198 Cr | +25.71% |
Total Liabilities | 75 Cr | +15.33% |
Total Equity | 122 Cr | +33.07% |
Shares Outstanding | 0.96 Cr | -0.14% |
Price to Book | 4.91 | -18.29% |
Return on Assets | 17.24% | -4.43% |
Return on Capital | 35.37 Cr | -9.79% |
Cash Flows
(INR) | Y/Y Change | |
Net Income | 30 Cr | +23.68% |
Cash from Operations | 23 Cr | -21.09% |
Cash from Investing | -19 Cr | -12.32% |
Cash from Financing | -2 Cr | +154.64% |
Net Change in Cash | 1 Cr | -73.37% |
Free Cash Flow | 5 Cr | -49.31% |
Peers
SUNPHARMA
Sun Pharmaceutical Industries Ltd
PE Ratio
41.42
1Y Return
▲53.96%
CIPLA
Cipla Ltd
PE Ratio
29.94
1Y Return
▲51.71%
DRREDDY
Dr Reddy's Laboratories Ltd
PE Ratio
19.27
1Y Return
▲24.69%
ZYDUSLIFE
Zydus Lifesciences Ltd
PE Ratio
31.97
1Y Return
▲88.18%
FAQs on Beta Drugs Ltd
How to buy Beta Drugs Ltd stocks?
You can easily buy the stocks/shares of Beta Drugs Ltd (BETA) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.
What is the Share Price of Beta Drugs Ltd?
The stock price of Beta Drugs Ltd as on 18 Apr 2024 is ₹1,379.95
What is the 52-week High and Low of Beta Drugs Ltd?
The 52-week high and low of Beta Drugs Ltd (BETA) is ₹1,595 and ₹660.
What are the peers or stocks similar to Beta Drugs Ltd?
The peers or stocks similar to Beta Drugs Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.
Which sector does Beta Drugs Ltd belong to?
Beta Drugs Ltd (BETA) belongs to the Pharmaceuticals sector.
What is the Market Cap of Beta Drugs Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Beta Drugs Ltd (BETA) is ₹1,302 Cr as of 18 Apr 2024
Can't decide whether or not to buy Beta Drugs Ltd stocks? ⭐️
Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.